SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

BRINK, Adrian et al. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: Risk factors for acquisition and prevention. SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.7, pp. 599-601. ISSN 0256-9574.

    1. Brink AJ, Feldman C, Richards GA, et al Emergence of extensive drug resistance (XDR) among Gram-negative bacilli in South Africa looms nearer. S Afr Med J 2008;98:586-592. [ Links ]

    2. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-1798. [http://doi.org/10.3201/eid1710.110655] [ Links ]

    3. Gupta N, Lumbago BM, Patel JB, et al Carbapenem-resistant Enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis 2011;53:60-67. [http://doi.org/10.1093/cid/cir202] [ Links ]

    4. Brink AJ, Coetzee J, Clay C, et al. Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol 2012;50:525-527. [http://doiorg/10.1128/JCM.05956-11] [ Links ]

    5. Kontopoulou K, Protonotariou E, Vasilakos K, et al Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 -lactamase resistant to colistin J Hosp Infect 2010;76:70-73. [http://dolorg/10.1016/j.jhin.2010.03.021] [ Links ]

    6. Zarkotou O, Pournaras S, Voulgari E, et al Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study. J Clin Microbiol 2010;48:2271-2274. [http://doi.org/10.1128/JCM.02301-09] [ Links ]

    7. Brink AJ, Botha RF, Poswa X, et al Antimicrobial susceptibility of Gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004 - 2009): Impact of the new carbapenem breakpoints. Surg Infect 2012;13:1-7. [http://doi.org/10.1089/sur.2011.074] [ Links ]

    8. Bamford C, Bonorchis K, Ryan A, et al. Antimicrobial susceptibility patterns of selected bacteraemic isolates from South African public sector hospitals, 2010. Southern African Journal of Epidemiology and Infection 2011;26:243-250. [ Links ]

    9. Kritsotakis EI, Tsioutis C, Roumbelaki M, et al. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-P-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother 2011;66:1383-1391. [http://doi.org/10.1093/jac/dkr116] [ Links ]

    10. Won SY, Munoz-Price LS, Lolans K, et al Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53:532-540. [http://doi.org/10.1093/cid/cir482] [ Links ]

    11. Patel N, Harrington S, Dihmess A, et al Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother 2011;66:1600-1608. [http://doi.org/10.1093/jac/dkr156] [ Links ]

    12. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumonia carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010;65:1119-1125. [http://doi.org/10.1093/jac/dkq108] [ Links ]

    13. Roberts JA, Kruger P, Paterson DL, et al Antibiotic resistance - what's dosing got to do with it? Crit Care Med 2008;36:2433-2440. [ Links ]

    14. Imberti R, Cusato M, Villani P, et al. Steady state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration. Chest 2010;138:1333-1339. [ Links ]

    15. Best Care ... Always! www.bestcare.org.za (accessed 17 February 2012). [ Links ]